If Donald Trump wins the presidency again in two weeks, this might be the ad that did it. It’s a spot called “Nonsense,” and it opens with a line so over the top, it feels like a parody ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali ...

Novartis said the European Medicines Agency has recommended its Kisqali cancer drug for market authorization. The drugmaker said Friday that the EMA's Committee for Medicinal Products for Human ...

The Zacks analyst believes that the planned launch of an in-house ad tech platform next year signals the ... However, the company's high debt load is a concern. Kisqali, Pluvicto Drive Novartis (NVS) ...

Former President Donald Trump’s campaign released a new ad Wednesday focused on Vice President Kamala Harris’ eyebrow-raising response to a question during her appearance on “The View ...

“If approved, Kisqali could provide an effective and tolerable adjuvant treatment option to mitigate the risk of recurrence in a broader patient population, particularly for patients who ...

We want to take a moment to tell you about a graphic political ad you may have seen airing on ABC stations. The ad is for anti-abortion rights advocate and presidential candidate Randall Terry and ...

EMA's CHMP issued a positive opinion for Novartis' Kisqali for high-risk early breast cancer. Kisqali showed a 25.1% reduced risk of cancer recurrence in Phase 3 NATALEE trial. The CHMP ...

Washington — Former President Donald Trump's campaign and his allies have spent tens of millions of dollars on political ads focusing on transgender rights issues in the weeks leading up to the ...

AND WITH KISQALI, I CAN HAVE BOTH. KISQALI IS A PILL THAT, WHEN TAKEN WITH AN AROMATASE INHIBITOR, HELPS DELAY CANCER FROM GROWING AND HAS BEEN PROVEN TO HELP PEOPLE LIVE SIGNIFICANTLY LONGER ...

In the first two weeks of October, Donald Trump and his allies directed about a third of all their spending on broadcast TV advertisements to ads about transgender health care, a significant ...